PetMed Express (PetMed Express) Risk Assessment

View and export this data going back to 1997. Start your Free Trial

What is PetMed Express Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of PetMed Express is: High Risk: Good fundamentals, beware of shrinking business.

Competitive Comparison of PetMed Express's Risk Assessment

For the Pharmaceutical Retailers subindustry, PetMed Express's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PetMed Express's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Risk Assessment distribution charts can be found below:

* The bar in red indicates where PetMed Express's Risk Assessment falls into.

PetMed Express (NAS:PETS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

PetMed Express Risk Assessment Related Terms

Thank you for viewing the detailed overview of PetMed Express's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

PetMed Express (PetMed Express) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PetMed Express Inc (NAS:PETS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

PQM:Germany PQM:Germany

Address

420 South Congress Avenue, Suite 100, Delray Beach, FL, USA, 33445

Website

https://www.petmeds.com

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.

Executives

Gian Fulgoni	director
Christine Chambers	officer: CFO	1501 1ST AVENUE SOUTH, STE. 600, SEATTLE WA 98134
Mathew N Hulett	director, officer: CEO & President	1621 NORTH KENT STREET, SUITE 1200, ARLINGTON VA 22209
Campbell Leslie C.g.	director	C/O COUPA SOFTWARE INC., 1855 S. GRANT STREET, SAN MATEO CA 94402
Diana G Purcel	director	C/O FAMOUS DVES OF AMERICA INC, 8091 WALLACE ROAD, EDEN PRAIRIE MN 55344
Moseley Mark Bradley Jr	other: Chief Technology Info Officer	420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Daniel Job Pingree	other: Chief Marketing Officer	420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Sandra Yvette Campos	director	4900 E DUBLIN GRANVILLE RD, COLUMBUS OH 43081
Jacqueline Paula Smith	other: Vice President of People	420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Carolyn Carden	other: VP of Product	420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Peter Cobb	director	DSW, INC., 810 DSW DRIVE, COLUMBUS OH 43219
Jodi Watson	director	420 SOUTH CONGRESS AVE., DELRAY BEACH FL 33445
Frank J Formica	director	1441 S.W. 29TH AVENUE, POMPANO BEACH FL 33069
Bruce S Rosenbloom	officer: Chief Financial Officer	6401 CONGRESS AVENUE, SUITE 250, BOCA RATON FL 33487
Menderes Akdag	director, officer: Chief Executive Officer	1441 S.W. 29TH AVENUE, POMPANO BEACH FL 33069